News: Veterinary Imaging Market Size, Share, Key Trends

 Increment sought after for veterinary diagnostics is required to fuel the interest as these gadgets are essentially utilized for ailments determination. The market for  veterinary imaging market is estimated to expand by exhibiting a CAGR of 7.14% during the forecast period and is estimated to reach value of USD 2,167.78 million by 2025.

Developing use on animals wellbeing and pet protection are required to add to expanding request. Moreover, developing partner animals fragment because of high selection of pets and increment in number of vet professionals around the globe are required to push the interest for these frameworks over the next years. Increment in rate of zoonotic sicknesses requests exact and compelling indicative devices, which is estimated to fuel the business growth in coming years. Interest for powerful solution for improve domesticated animals profitability in creating economies is relied upon to drive the selection in coming years 

Upsurge in populace of domesticated animals, appeal for dairy and meat items, ascend in reception of pets, and increment in mindfulness among pet proprietors for better treatment alternatives for their pets are a portion of the elements foreseen to add to development of the veterinary imaging market over the conjecture time frame. Veterinary indicative imaging comprises of a non-intrusive technique for getting pictures of the animal’s body with the end goal of restorative diagnostics. The animals considered for imaging are little friend animals, enormous animals, and zoo animals, and others. 

The market is driven by expanding consumption on animal wellbeing alongside rising interest for pet protection alongside developing pet market. Besides, specialized improvements identified with veterinary imaging instruments are required to offer inexhaustible development openings in the market. Absence of skilled veterinarians is a key market challenge looked by key market players.

Competitive Analysis:

The key players operating in the global veterinary imaging market include IDEXX Laboratories, Inc., Carestream Health, GE Healthcare, FUJIFILM Holdings America Corporation, Esaote SpA,Hallmarq Veterinary Imaging Ltd, VetZ Limited, SUNI Medical Imaging, Inc., and Universal Medical Systems, Inc.

Segmentation:

The veterinary imaging market is segmented based on product type, animal type, therapeutic areas, end user, and region.

In terms of product type, the global veterinary imaging market is categorized into instruments systems, veterinary software, and veterinary imaging reagents. Of these instruments systems is sub-segmented into ultrasound imaging systems radiography systems, magnetic resonance imaging systems, and computed tomography imaging systems. 

Based on the animal type, the market is segmented into small companion animals, large animals, and others.

Based on the therapeutic areas, the market is segmented into orthopedic and traumatology, neurology, cardiology, oncology, and other.

Based on the end user, the market is segmented into hospitals & clinics, academic institutes, and others.

Regional Analysis:

Based on the region, the market is segmented into Europe, the Americas, Asia Pacific, the Rest of the World (RoW). Of these, the Americas are estimated hold strong position in the veterinary imaging market is likely to expand with a CAGR of 7.62% during the forecast period. This is attributed to larger adoption of pets in the region. Increase in research and development (R&D) coupled with the demand for veterinary imaging equipment is driving the growth of the market. The increase in pet adoption along with increasing healthcare expenditure in the animal health segment is anticipated to propel the market growth. 

Asia Pacific market for veterinary imaging is anticipated to witness most lucrative growth owing to rising healthcare expenditure. Additionally, the increase in interest of key players for investing in this market is benefiting the market growth in the region. Rising interest of companies to expand their across the region along with growing demand for veterinary products are driving growth of the global veterinary imaging market. In addition to this, increasing R&D investment, availability of low-cost animal health products, and rising healthcare expenditure are expected to drive the growth of market.

Read More @ https://www.marketresearchfuture.com/reports/veterinary-imaging-market-2919 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

Blog: https://healthcarenews12.blogspot.com/

3D Printing Medical Devices Market Demand- Global Analysis and Growth Factors

 3D printing functions an essential part of the medical and dental manufacturing sector and is the preferred choice of medical device manufacturers, for its cost-effective production of all types of medical devices such as the custom-made knee, hearing aids, hip implants, and prostheses.

Global 3D printing medical devices market is anticipated to grow due to influential factors such as the increase in investment by the growing use of 3D printing device in the healthcare industry the governments towards the healthcare sector, rising technological advancements in 3D printing, and easy production of medical devices. 

Free Sample Copy with Considering Coivd19 Impact on this Market @ https://www.marketresearchfuture.com/sample_request/6830 

According to a report issued by Market Research Future (MRFR), the global 3D printing medical devices market has been assessed to grow at a CAGR of 18% during the forecast period from 2018 to 2023. 

Segmental Analysis

The global market for 3D printing medical devices market has been segmented into types, component, technology, application, end-users, and regions.

Based on types, the global 3D printing medical device market has been segmented into prosthetics & implants, surgical guides, surgical instruments, and tissue engineering product. The surgical guide segment has been assessed to account for the largest market share in the type segment over the forecast period, due to its advantage of providing accurate implant restoration, resulting in a rise in the demand for the surgical guide has been increasing, and this is a crucial factor driving the growth of this market segment.

Based on the component, the market for 3D printing medical devices has been segmented into the 3D bioprinter, 3D printer, materials, software & services, and system. Software & services segment is projected to account for the largest market share in the component segment over the forecast period, due to the increase in advancements in the software solutions for manufacturing high-quality 3D-printed medical products.

On the basis of technology, the 3D printing medical device market has been segmented into 3D printing, droplet deposition, electron beam melting (EBM), laminated object manufacturing (LOM), laser beam melting, photopolymerization, poly-jet technology, and others. Photopolymerization segment has been assessed to account for the largest market share in the technology segment over the forecast period.

Based on application, the global market for 3d printing medical device has been segmented into clinical study devices, external wearable devices, implants, and tissue engineering. The external wearable devices segment assessed to account for the largest market share in the application segment over the forecast period.

By end-users, the market has been segmented into academic institutions, contract research organization, hospitals, medical and surgical centers, and pharma and biotech companies. The medical and surgical centers segment has been assessed to account for the largest market share in the end-user segment over the forecast period,  due to the increase in the  patient population and decrease in surgical and infection risks.

Based on the region, the market has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.

Regional Analysis

North America has been expected to dominate the global 3D printing medical device market over the forecast period, due to the growth in the demand for organ transplant surgeries in the region, and the increase in investments made by the government towards the research and development of advanced 3D printing technologies.

Europe is the second-largest regional market for 3D printing medical devices, owing to favorable government investments, rise in research and development. Additionally, the changing lifestyles of consumers have led to an increase in patient population and number of surgeries, consequently contributing to the growth of the 3D printing medical device market in the region.

Asia-Pacific has been assessed to grow as the fastest-growing region in the 3D printing device market through the forecast period, due to the growing prevalence of chronic diseases such as diabetes, blood pressure disorders among others, the increasing investments in the healthcare sector by the government, and increase in the geriatric population.

The Middle East & Africa region has been accounted for the comparatively smallest market share in the global 3D printing medical devices market owing to a healthcare sector that needs improvement, lack of medical knowledge, and inadequate medical facilities.

Key Players

The key players identified in the global 3D printing medical devices market are 3D Systems Corporations, 3T RPD Ltd., Arcam AB, Bio3D Technologies, EnvisionTEC, Cyfuse Medical K.K.EOS GmbHConcept, Laser GmbH, Materialise NV, Organovo Holdings, Inc., Oxford Performance Materials, Inc., Renishaw plc, Prodways Group, Stratasys Ltd., and SLM Solutions Group AG.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Animal Genetics Market 2021 Global Analysis, Size, Share, Emerging Trends, Regional Outlook, Leading Growth Drivers and Industry Forecast to 2027

 Market Highlights:

The Animal Genetics Market is expected to witness tremendous growth owing to as increased adoption of genetic services to prevent genetic diseases and business loss, and rising acceptance of advanced genetic technologies. Other key factors such significant investments in R&D and expansions undertaken by key players are contributing towards the growth of the market. However, challenges such as need for specific breeding programs for breeds with inferior economic performance, and economic sustainability in local breeds is likely to curb the market growth during the forecast period.
Get Free Sample!! https://www.marketresearchfuture.com/sample_request/7004  

Key Players:
Some of the key players in the global animal genetics market are Neogen Corporation (US), Genus (UK), URUS (US), EW Group (Germany), Groupe Grimaud (France), CRV Holding B.V. (The Netherland), Topigs Norsvin (Netherlands), Zoetis (US), Envigo (US) Hendrix Genetics BV (The Netherland), Animal Genetics (US), Alta Genetics (US), vetGen (US), and others.

Regional Analysis:
The Americas is the largest in the market owing to the high acceptance of animal genetics in research, the development in research expenditure along with the increasing acquisition by the market players are also accountable for the growth of the animal genetics market. For instance, in 2018, Neogen completed the acquisition of Livestock Genetic Services, a firm that specializes in genetic evaluations and data management for cattle-breeding organizations. This strategy enhances the company’s in-house genetic evaluation capabilities and further expands the company’s global network of animal genomics laboratories.

The European region is the second largest animal genetics market over the forecast period due to high consciousness about animal wellbeing coupled with increased expenditure on veterinary services in the region. As per a report by the European Pet Food Industry Federation, more than 75 million households in Europe own a pet.

The Asia Pacific region is likely to develop at the uppermost CAGR for the animal genetics market in the years to come. Moreover, the rising veterinary care services both at the veterinary hospital and at community level are expected to influence the market in a positive way.

The Middle East and Africa accounts for the least share due to low per capita income and lack of availability of well-trained healthcare professionals. However, there has been an increasing demand for test accuracy and consistency among end-users and the government in this region that is enhancing the adoption of animal genetic technology in this region.

Segmentation:
The Global Animal Genetics Market is segmented into animal genetic products, services, and end-user. The Animal Genetics Market, by animal genetic products, the market is segmented into genetic materials and live animals. The live animals are further bifurcated into poultry, bovine, porcine, canine and others. The genetic materials are sub-segmented into semen and embryo. On the basis of services, the animal genetics market is bifurcated into genetic disease tests, DNA typing, gene trait tests, and others. On the basis of end-user, the market is segmented into veterinary hospitals & clinics, diagnostic centers, research centers and institutes, and others

Browse Complete Report @  https://www.marketresearchfuture.com/reports/animal-genetics-market-7004

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Global Breast Imaging Market Industry Analysis, Size, Share, COVID 19 Analysis ,Growth, Trends and Forecast – Year 2027

 

Market Synopsis

The global breast imaging market is considered to demonstrate 8.5% CAGR during the forecast period (2017-2023) owing to increasing prevalence of breast cancer, asserts Market Research Future (MRFR). Breast imaging is referred to a diagnostic procedure which evaluates the presence of breast tumor in women. Breast biopsy ultrasound, mammography, PET, CT, MRI, tactile imaging, and others are some of the common breast imaging procedures. Among these, mammography is the most widely used screening tool and diagnosis for breast cancer and helps to detect breast cancer at an early stage. According to the World Health Organization, breast cancer has been reported as the second most common cancer among the women population.

Get Free Sample Copy@ https://www.marketresearchfuture.com/sample_request/5612 

Drivers and Constraints Impacting the Market

With the rising prevalence of breast cancer, the global breast imaging market is anticipated to flourish during the assessment period. More than 200,000 new cases of cancer are diagnosed every year across the globe. The increasing expenditure on healthcare by the developed countries coupled with the technological developments in the field of oncology across the world has further contributed to the market growth. Moreover, the emergence of new imaging technologies for screening and diagnosis of several chronic diseases have influenced the market growth to a great extent. Several companies conduct corporate social responsibility activities to help women educate regarding breast health and its preventive measures. For instance, companies like GE Healthcare have recently launched a commercial regarding the awareness of breast density and its effect on screening techniques. With the increasing awareness, the demand for breast imaging is predicted to expand in during the appraisal period.

On the flip side, the high cost of breast imaging solutions coupled with the unawareness about breast imaging among the women population are predicted to dampen the market growth during the estimated period. Moreover, most of the women are reluctant to undergo breast imaging owing to a number of misconceptions about the disease. This is considered to restrict the market growth in the coming years.

Global Breast Imaging Market: Segmental Analysis

The global breast imaging market has been segmented on the basis of type, application, deployment, end-user, and region.

By mode of type, the global breast imaging market has been segmented into CT, mammography, MRI, PET, breast biopsy, ultrasound, tactile imaging, and others. Among these, the mammography segment has been further sub-segmented into full-field digital mammography (FFDM), film-screen mammography, scintimammography or molecular breast imaging, 3D mammography, and others. The breast biopsy segment has been sub-segmented into tactic core biopsy, image-guided breast biopsy, ultrasound-guided core biopsy, and others.

By mode of application, the global breast imaging market has been segmented into post-neoadjuvant chemotherapy, breast cancer diagnosis, metastatic axillary adenocarcinoma, and others.

By mode of end-user, the global breast imaging market has been segmented into diagnostic centers, hospitals, and others.

Regional Insights

Geographically, the breast imaging market span across regions namely, America, Asia Pacific, Europe, and the Middle East & Africa.

Among all the regions, America is considered to be the largest market for breast imaging. The growth is attributed to the growing prevalence for breast cancer, innovative imaging solutions for breast imaging, and development of new imaging devices by the major market players. The market in the North American region is driven by the extensive use of imaging modalities like CT, mammography, and MRI for screening of breast cancer. The U.S. is considered to hold the largest market share owing to the presence of major players coupled with emphasis on women healthcare.

The European market is presumed to exhibit a significant growth owing to an increased expenditure on research and development activities by the major countries like U.K. The market in Germany is expanding at a substantial rate owing to an extensive use of available imaging technologies for breast imaging coupled with the exponential growth of medical devices industry. Moreover, the urge of developing new imaging devices for early cancer screening is also considered to contribute to the market growth in this region.

The Asia Pacific region showcases numerous growth opportunities owing to the presence of some of the largest contributors such as China, Japan, and India. With rising awareness about breast cancer along with the use of medical devices for cancer screening, the breast imaging market is likely to accelerate in this region. Moreover, the rapid growth of healthcare imaging industry in China and India and rising government support for improvement in the diagnostic services and healthcare infrastructure contributes to the market growth.

Industry Updates

December 04, 2018: The Ultrasound Breast Imaging Center has opened in Walnut Creek. This ultrasound 3D breast imaging involves no compression, no radiation, and no injections.

 

Competitive Dashboard

The prominent players operating the global breast imaging market are Sonocine Inc. (U.S.), Fujifilm Holdings Corporation (Japan), General Electric Company (U.K.), Hologic Inc. (U.S.), Dilon Technologies Inc. (U.S.), Gamma Medica Inc. (U.S.), Toshiba Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Siemens (Germany), Aurora Imaging Technology Inc. (U.S.), and others.

Access Report Details @ https://www.marketresearchfuture.com/reports/breast-imaging-market-5612 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Anti-viral drugs Market 2021 Global Size, Key Vendors Analysis, Industry Growth, Segmentation, Future Trends, Statistics, Opportunities and Regional Forecast 2027

 Market overview 

Viruses are the parasites that derive the nutrition from the host cells and direct the metabolic machinery for synthesizing the new virus particles. These viruses can live and duplicate inside the host body. Antiviral drugs are used for treating such viral infections and act by inhibiting the target viruses. These drugs are used for the treatment of various chronic diseases and infections such as HIV, influenza and hepatitis. There are broad spectrum antiviral drugs that can be used for treating such viral infections. 

Download Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/2454 

Moreover, several investigational drugs are being researched and developed, a lot of money is being invested and there has been a rise in the healthcare expenditure with the emergence of life-threatening diseases and the increase in the incident rates of viral infections, mainly HIV. The World Health Organization has estimated that 36.7 million people are suffering from HIV/AIDS all over the world with 1.1. Million deaths in the year 2015. The increasing prevalence of viral infections is expected to increase the demand and supply for antiviral drugs. 

The global antiviral drugs market report takes all the factors into consideration and focuses on the market value that is expected to reach USD 2.67 billion by the end of the forecast period of 2022, with a healthy CAGR of 6.9%. It is estimated that there were almost 257 million patients that were living with the hepatitis B virus for the year 2015. This will boost the demand for efficient treatment solutions using the antiviral drugs. 

Market segmentation

For combating the drug resistance, there has been a combination of various antiviral drugs that will have different mechanisms. The overall antiviral drugs market can be segmented based on the applications and mechanism of actions.

On the basis of application, the global antiviral drugs can differ as:

• HIV/AIDS 
• Herpes
• Hepatitis
• Influenza
• Others

Abd based on the mechanism of action, the global antiviral drugs maret can be split into:

• Reverse transcriptase inhibitors, polymerase inhibitors
• Protease inhibitors 
• Others

There are various market factors that are contributing to the growth of the global anti-viral drugs market share . The combination antiviral treatment is the typical care for HIV and hepatitis C virus contamination. It was decided this method is becoming popular increasingly with other viral infections. 

Regional analysis 

In order to combat drug resistance, the combination of various antivirals with different mechanisms of action is used. Combination therapy againsts viruses is the basis of care in HIV and hepatitis C virus infections, and it is likely to become increasingly used in other viral infections. America is the largest market where North America will be taking the share greater than 30%. Europe is the second-largest market in the anti-viral drugs market and Asia-Pacific region will be growing at a faster rate in the antiviral drugs market. The report presents the detailed analysis of the qualitative and quantitative aspects of the various industries. 

Industry news 

Abbott Laboratories ABT has announced the launch of a lab-based serology blood test for detecting the presence of the antibody IgG that will tell if the person has coronavirus or not. This test was previously available on Abbott’s ARCHITECT i1000SR and i2000SR laboratory instruments. The company has taken the third test for coronavirus after the m2000 molecular laboratory system and other point-of-care devices.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Veterinary POC Diagnostic Market: Industry Analysis, Size, Share, Growth, Trends, And Forecasts – 2027

 Global Veterinary POC Diagnostic Market: By Product (Consumable, Instruments), By Technology (Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, Molecular Diagnostics), By Application (Clinical pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, Neurology), By Animal Type (Companion Animals, Livestock Animals) By End User (Veterinary Hospitals and Clinics, Home Care Settings) and Region (Americas, Europe, Asia-Pacific, Middle East & Africa) - Forecast to 2027

According to MRFR analysis, the Global Veterinary POC Diagnostic Market is expected to register a CAGR of 8.9% during the forecast period of 2020 to 2027 and reach USD 2,894 Million by 2027.

Changes in veterinary healthcare system like Point-of-Care (POC), it enables rapid results in non-laboratory settings. There is traction in the veterinary point-of-care diagnostics market due to the adoption of advanced and innovative diagnostic testing methods.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/10018 

The growth of the global veterinary POC diagnostic market can be attributed to the growing need for rescue medication, demand for POC diagnostic in the field of veterinary as the diseases in animals is increasing and affecting the human being as well.

Furthermore, growing companion animal population, growing prevalence of animal zoonotic diseases, rising demand for pet insurance & growing animal health expenditure, an increasing number of veterinary practitioners, increase in income levels in developed economies are expected to fuel the market growth during the forecast period.

However, the increasing pet care costs and high cost of veterinary imaging instruments are expected to restrain the growth of the global veterinary POC diagnostic market report.

Several market players such as IDEXX Laboratories, Heska Corporation, and Fujifilm among others currently dominate the global veterinary POC diagnostic market. The key players are involved in awareness campaigns, product approvals, mergers, and strategic collaborations to strengthen their market positions, for instance, In January 2020, IDEXX launched the Vcheck Feline NT-proBNP test kit, In January 2020, Heska Corporation acquired SCIL Animal Care Company (Germany) to complement the company's veterinary diagnostics portfolio and expand the geographic portfolio across North America and greater Europe and reach over to 25 countries across these regions., In July 2019, Fujifilm Corporation established FUJIFILM VET Systems Co., Ltd in Japan to supply its veterinary products segment to veterinary clinical practices in the country. This expansion would enhance the company's veterinary medicine business in Japan. In January 2018, IDEXX launched the IDEXX Catalyst SDMA Test.

Veterinary POC Diagnostic Market Regional Analysis

The market has been divided, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas region held the largest market in 2019, owing to the rising animal zoonotic diseases in the region. The veterinary POC diagnostic market in the Americas has further been branched into North America and Latin America, with the North American market divided into the US and Canada. The European veterinary POC diagnostic market has been categorized as Western Europe and Eastern Europe. The Western European market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe. The veterinary POC diagnostic market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. Due to the increasing zoonotic diseases, the market in Asia-Pacific is expected to be the fastest-growing. The veterinary POC diagnostic market in the Middle East & Africa has been divided into the Middle East and Africa.

Veterinary POC Diagnostic Market Segmentation

Global Veterinary POC Diagnostic Market has been segmented based on the Product, Technology, Application, Animal Type, and End User.

Based on the type, the global veterinary POC diagnostic market has been segmented into Consumable, Instruments. The consumable segment is expected to hold the largest market Share owing to the increasing demand for the rapid detection of diseases, the growing prevalence of animal zoonotic diseases.

On the basis of technology, the market has been segmented into Clinical Biochemistry, Immunodiagnostics, Hematology, Urinalysis, and Molecular Diagnostics. Clinical Biochemistry is expected to hold a major market share due to the higher preference for various advanced clinical diagnostic products by veterinarians and pet owners are contributing to the large share of this segment.

Based on the application, the market has been segmented into Clinical Pathology, Bacteriology, Virology, Parasitology, Orthopedics & traumatology, Gynecology, Oncology, Cardiology, and Neurology. Clinical pathology is expected to grow at the fastest CAGR.

The market based on end user has been segmented into hospitals & clinics, home care, and others. The hospitals and clinics segment is expected to hold the largest market share owing to the larger patient footfall in hospitals.

Based on the animal type, the market has been segmented into Companion animals, Livestock Animals. Clinical pathology is expected to grow at the fastest CAGR.

Key Players

Thermo Fisher Scientific, Inc. (US), Idexx Laboratories, Inc. (US), Zoetis, Inc. (US), Virbac (France), Heska Corporation (US), Eurolyser Diagnostica GmbH (Austria), Woodley Equipment Company Ltd. (UK), Randox Laboratories, Ltd. (UK), AniPoC, Ltd. (UK), Carestream Health, Inc. (US), Neurologica Corporation (US), Fujifilm Sonosite, Inc. (Japan), Diagnostic Imaging Systems, Inc. (US), Esaote spa (Italy), Mindray Medical International Limited (A Part of Excelsior Union Limited) (China), GE Healthcare (US), Minxray, Inc. (US), QR s.r.l. (Italy), Sedecal (Spain), Examion GmbH (Germany)

Table Of Contents

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Veterinary POC Diagnostic Market, By Product

1.1.2. Global Veterinary POC Diagnostic Market, By Technology

1.1.3. Global Veterinary POC Diagnostic Market, By Application

1.1.4. Global Veterinary POC Diagnostic Market, By Animal Type

1.1.5. Global Veterinary POC Diagnostic Market, By End User

1.1.6. Global Veterinary POC Diagnostic Market, By Region

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope Of The Study

2.3. Market Structure

3. RESEARCH METHODOLOGY

3.1. Research Process

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

3.5. Forecast Model

3.6. List Of Assumptions

4. MARKET DYNAMICS

4.1. Introduction

4.2. Drivers

4.2.1. Growth In The Companion Animal Population

4.2.2. Increasing Prevalence Of Zoonotic Diseases

Continued...

Browse Full Report Details @ https://www.marketresearchfuture.com/reports/veterinary-poc-diagnostic-market-10018

 About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com 

Veterinary Vaccines Market Top Leading Countries, Companies, Consumption, Drivers, Trends, Forces Analysis, Revenue, Challenges and Global Forecast 2023

 Veterinary/Animal Vaccines Market Information: By Type (Livestock Vaccines, Porcine Vaccines), Technology (Live Attenuated Vaccines, Inactivated Vaccines), and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa)—Global Forecast till 2025

Overview:

Be it as a means for food or as pets, animals have an age-old relationship with human beings. That is why the well-being of these animals become all the more necessary. Hence, veterinary vaccines are gaining traction across the Middle East & Africa (MEA). Veterinary vaccines ensure improved health and increased production of the livestock and reduce cost substantially. At the same time, it prohibits the transmission of diseases to other animals or human beings. Climate is playing a crucial role in triggering growth in number of the cases registered with animals getting affected by diseases. The second factor constantly influencing the market is the increase in spending on companion animals. This makes the owners seek assistance to apply veterinary vaccines to their animals to ensure their healthy life as well as of people around the animal. The region has a huge number of unvaccinated livestock which is becoming a concern as the dairy and meat sectors are also burgeoning. Hygiene has always been a problem with this region, and this can result in animals getting affected by diseases. And factors can have a knock-down effect on the MEA veterinary vaccines market and aid it to inflate with CAGR 7.1% during the forecast period (2013-2022) to reach USD 550.84 million, asserts Market Research Future (MRFR) in a detailed study.

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/2687 

However, research and development in this sector can incur high investment which considering the end price of products may not seem beneficial. This can give the veterinary vaccines market an unwanted jolt. The market is also getting steep competition from its Chinese counterparts, and the animal industry is fairing poorly as Europe is gaining the upper hand in the region.

Segmentation:

The MEA market for veterinary vaccines can be segmented by technology, disease indication, composition, and animal type.

Technology-wise, the market can be segmented into attenuated, inactivated, toxoid, conjugate, subunit and recombinant DNA. Growing number of farms and animals as companions have given rise to attenuated segment which is currently dominating the market and the situation is expected to remain so in the foreseeable future.

Based on disease indication, the market includes foot & mouth disease, parvovirus, distemper, reproductive & respiratory syndrome and others.

Composition-based segmentation comprises mono vaccine and combination vaccines.

Based on animal type, the market consists poultry, bovine, porcine, companion and other. Poultry segment is accounted for the maximum market share followed by porcine. Meanwhile, companion section is witnessing significant market growth owing to the trend of adoption of pets.

Access Report @ https://www.marketresearchfuture.com/reports/mea-veterinary-vaccines-market-2687 

Regional Analysis:

The MEA market for veterinary vaccines can be segmented into the UAE, Egypt, Saudi Arabia, Kuwait, Qatar, and Oman.

The UAE has the largest market for veterinary vaccines. The region has a well-formed healthcare setup that looks into the issue, and people with disposable income are also fond of pets which give the market considerable leverage in exploring significant possibilities.

Egypt is currently holding the second position. The local market here is driven by growing demand for meat and dairy product and to safeguard the source of such food and beverage, vaccines are necessary. Weather in the African continent is harsh but is ideal for diseases which spreads quite rapidly. Animals and human beings living in close proximity also increase chances of infection transmission which has to be taken into consideration for a better lifestyle.

Market Competition:

The market is getting some recognition from the concerned authorities as it can benefit from the associated industries significantly. Presence of several foreign companies in the region is also proving vital for the market.

Some of the key players in this market are Zoetis Inc., Boehringer Ingelheim GmbH, Merck Animal Health, MSD Animal Health, Elanco Animal Health, Bayer AG, Indian Immunologicals Limited, and others.

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/ 

Urgent Care Apps Market | COVID-19 Analysis and Industry is estimated to grow at a CAGR of 42.8% by Forecast to 2025

 Urgent Care Apps Market Research Report by Type (Emergency care triage apps, In-hospital communication & collaboration apps, and Post-hospital apps), Clinical Area (Trauma, Stroke, Cardiac conditions, and Others), and Region (America, Europe, APAC, RoW)-Global Forecast to 2027

Urgent Care Apps Market Overview

Market Research Future (MRFR) perceives the market to advance at a remarkable CAGR of 42.20% over the forecast period and acquire USD 2597.8 Mn by the end of 2023. 

Market Dynamics

The growing awareness of the loopholes of the current distribution system for healthcare, along with the general movement towards personalized medicine, has had a far-reaching impact on the development of the global demand for emergency care applications. Apps for urgent care have been a way of reducing lengthy wait times and high ER rates. They will, however, greatly reduce healthcare costs and serve as a catalyst for patient interaction. The massive popularity of emergency care software can be attributed to the ubiquity of software, fueled by the deep penetration of tablets, computers, and smartphones. A sufficient number of smartphone users render their mobile devices essential for health-related or medical information to be sought.

Get Free Sample PDF Brochure @ https://www.marketresearchfuture.com/sample_request/6677

However, inadequate internet access and low penetration of smartphones and 3G/4G networks in underdeveloped regions have hindered the development of urgent care applications in those regions. The growth of the industry remains a problem for a vast number of miscategorized applications.

In addition, the growth in the number of mobile users, the increase in internet usage, the increase in the usage of smartphones, the increase in 3G and 4G innovations, the increase in spending by different organisations to develop healthcare and network connectivity, and the growing demand for cost-effective and user-friendly technology are driving the development of different markets for emergency service applications. While healthcare technologies such as emergency response applications have yet to enter the mainstream, in the modern healthcare environment, they are considered an innovation. Growing knowledge of health management apps creates opportunities for business expansion.

Urgent Care Apps Market Regional Analysis

The Americas, Europe, Asia Pacific, and the Middle East & Africa are the key markets for urgent care apps. 

North America, led by North America, is a major market for urgent care applications. The demand in North America is growing with deep penetration of smartphones and 3G and 4G networks along with increasing healthcare costs and the persistent need to tackle the same. In addition, the area continues to respond rapidly to new technology that further boost the expansion of the demand for emergency care applications. Some of the main factors leading to market growth in the area are the increasing acceptance of digital technologies in healthcare, the existence of well-established healthcare networks, and strong smartphone penetration. Other driving forces include raising awareness about customized healthcare and rising emphasis. In addition, increasing the production and implementation of advanced and sophisticated digital technologies, the presence in the area of a vast number of players operating across sectors such as mobile and network operations, and high costs associated with in-patient treatment further contribute to market growth.

The rise of the European market can be attributed solely to rising government policies to encourage such applications and to an immense need to reduce healthcare costs. The main markets in Europe are Germany, Italy, France, Spain, and the UK.

The Asia Pacific demand for urgent care applications is predicted to expand steadily in the coming years. Growing mobile penetration in Asia Pacific's developing economies, combined with growing knowledge of healthcare management applications, can be certified for the growth of the Asia Pacific emergency care apps industry. Any of the key drivers projected to push the demand in the region are the increasing number of government programs, the investments by non-profit organisations and private businesses to promote the adoption of urgent care applications for effective knowledge sharing, increased patient experience, improved treatment quality, cost savings, and easy service. 

 Urgent Care Apps Market Segmental Analysis

The Global Urgent Care Apps Market share has been segmented based on type and clinical area. 

By type, the urgent care apps market has been segmented into emergency care triage apps, in-hospital communication & collaboration apps, and post-hospital apps. The segment of post-hospital apps has been further segmented into medication management apps, communication & collaboration apps for care providers, and rehabilitation apps.

The global market for urgent care apps has been segmented into trauma, stroke, cardiac conditions, and others by clinical area. Because of the increasing incidence of road accidents, the trauma segment is the largest segment that requires trauma care and increased awareness by healthcare organizations to address trauma. Leading to the incremental awareness of the advantages of urgent care applications in the treatment of serious cardiac problems, the section of cardiac conditions is projected to be the fastest growing segment. However, over the estimated span, the stroke segment is predicted to emerge at a substantial growth rate.

Urgent Care Apps Market Competitive Landscape

Some of the prominent players operating in the global urgent care apps market include Forward Health, Pivot Design Group, Johnson & Johnson, Twiage, Siilo, Alayacare, PatientSafe Solutions, Vocera Communications, Hospify, Argusoft, Voalte, Pulsara, Imprivata, Allm, and TigerConnect. 

Browse Complete Report @ https://www.marketresearchfuture.com/reports/urgent-care-apps-market-6677

LIST OF TABLES

Table 1 Global Urgent Care Apps Market Synopsis, 2018–2023

Table 2 Global Urgent Care Apps Market Estimates And Forecast, 2018–2023, (USD Million)

Table 3 Global Urgent Care Apps Market, By Region, 2018–2023, (USD Million)

Table 4 Global Urgent Care Apps Market, By Type, 2018–2023, (USD Million)

Table 5 Global Urgent Care Apps Market, By Clinical Area, 2018–2023, (USD Million)

Table 6 North America Global Urgent Care Apps Market, By Type, 2018–2023, (USD Million)

Table 7 North America Global Urgent Care Apps Market, By Clinical Area, 2018–2023, (USD Million)

Table 8 US Urgent Care Apps Market, By Type, 2018–2023, (USD Million)

Table 9 US Urgent Care Apps Market, By Technology, 2018–2023, (USD Million)

Table 10 US Urgent Care Apps Market, By Clinical Area, 2018–2023, (USD Million)

Continued….

LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation For Global Urgent Care Apps Market

Figure 3 Segmentation Market Dynamics For Global Urgent Care Apps Market

Figure 4 Global Urgent Care Apps Market Share, By Type 2017

Figure 5 Global Urgent Care Apps Market Share, By Clinical Area, 2017

Figure 6 Global Urgent Care Apps Market Share, By Region, 2017

Figure 7 North America Urgent Care Apps Market Share, By Country, 2017

Figure 8 Europe Urgent Care Apps Market Share, By Country, 2017

Figure 9 Asia Pacific Urgent Care Apps Market Share, By Country, 2017

Figure 10 Middle East & Africa Urgent Care Apps Market Share, By Country, 2017

Continued….

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/

Diabetic Retinopathy Market is expected to expand at 11.9% CAGR during the forecast period 2018-2025

 Market Synopsis:

Market Research Future (MRFR)’s study reveals that the global diabetic retinopathy market is anticipated to expand at a CAGR of 5.2% during the forecast period 2017 to 2023. The rising burden of diabetes is prognosticated to emerge as the driving force of market growth. In addition, rising awareness about the disease has intensified the need for advanced diagnostic tests for early diagnosis. This, in turn, is forecasted to accelerate the revenue creation for the market participants.

Changes in lifestyle are fueling the threat of diabetes across the world. It is likely to influence the growth of the diabetic retinopathy market positively in the forthcoming years. Key players are investing in research & development for bringing technologically advanced devices and diagnostics in order to treat the disease effectively. It is presumed to encourage the expansion of the diabetic retinopathy market over the next few years.

The growing geriatric population is supposed to favor the proliferation of the market. On the flip side, inaccuracy of some diagnostic tests, lack of awareness about the disease, and low healthcare expenditure in developing nations are prognosticated to check the expansion of the diabetic retinopathy market in the through the assessment period.

Market Segmentation:

By type, the global diabetic retinopathy market has been segmented into non-proliferative diabetic retinopathy and proliferative advanced diabetic retinopathy.

By diagnosis, the diabetic retinopathy market has been segmented into fluorescein angiography and optical coherence tomography.

By treatment, the global diabetic retinopathy market has been segmented into laser treatment, anti-VEGF Therapy, vitrectomy, and others. The laser treatment is sub-segmented into focal laser treatment and scatter laser treatment.

By end-user, the diabetic retinopathy market share has been segmented into hospitals and clinics, diagnostic centers, research institutes, and others.

Regional Analysis:

The global diabetic retinopathy market, by region, has been segmented into Americas, Europe, Asia Pacific, and the Middle East & Africa. Americas is expected to hold the largest share of the global market over the assessment period. Led by the U.S., this region is poised to benefit from the rising awareness about the disease and the increasing demand for early diagnosis. An upsurge in demand for diagnostic tests is also projected to be witnessed in the diabetic retinopathy market across the review period. The consolidation of key players in the region is further prognosticated to augment the regional diabetic retinopathy market in the foreseeable future.

Increasing patient population and availability of diagnosis for diabetes are driving the market growth in Europe. Germany is anticipated to contribute substantially over the next couple of years. Other factors forecasted to aid the proliferation of the diabetic retinopathy market in the region are high demand for early diagnosis, increasing research & development, changing lifestyle, etc.

Factors such as high prevalence of chronic diseases, presence of a huge geriatric population, lifestyle changes, etc. are poised to expedite the growth trajectory of the diabetic retinopathy market in Asia Pacific. Meanwhile, the Middle East & Africa is expected to exhibit steady growth driven by the increasing demand for diabetes management.

Competitive Dashboard:

Some of the key players profiled in the report are Novartis AG (Germany), Regeneron Pharmaceuticals Inc. (U.S.), Kowa Group (Japan), Bayer (Germany), ThromboGenics (U.S.), Sirnaomics (U.S.), Glycadia Pharmaceuticals (U.S.), Actavis Plc (U.K.), Ampio Pharmaceuticals (U.S.), Genentech (U.S.), Alimera Sciences (U.S.), and BCN Peptides (Spain).

Industry News:

In January 2019, Brazilian and Australian researchers have developed an algorithm that leverages artificial intelligence technology for spotting key marker of diabetic retinopathy with 98% accuracy.

In January 2019, a camp was organized in Hyderabad, India, under the auspices of Indian Institute of Public Health (IIPH, Hyderabad) for raising awareness about diabetic retinopathy.

In December 2018, Google has developed an AI model that detects diabetic retinopathy with an accuracy of human retinal specialists. It is rolling out its diabetic retinopathy initiative in India with Verilywhich works on life sciences research and development.

In April 2018, The U.S. Food & Drug Administration (FDA) has permitted the marketing of the first AI-based device that facilitates the detection of diabetic retinopathy.

Read more @ https://www.marketresearchfuture.com/reports/diabetic-retinopathy-market-5792 

Cranial fixation and stabilization devices Market | COVID-19 Pandemic Impact, Size, Share, Global Demand, Business Statistics and Forecast to 2027

 The global cranial fixation and stabilization market is growing pervasively. The increasing prevalence of neurological conditions such as epilepsy, stroke, neuroinfectious, and traumatic injuries is a major growth propeller. Rising numbers of bone and head injury cases, road accidents, and spinal cord injuries are influencing the growth of the market. Moreover, increasing R&D expenditures and aggressive strategies adopted by the top players, such as new product launches are escalating the market on the global platform. 

Get Free Sample @ https://www.marketresearchfuture.com/sample_request/8163  

According to Market Research Future (MRFR), the global cranial fixation and stabilization market is poised to touch a valuation of USD 2.29 BN by 2025. In its recently published analysis, MRFR also asserts that the market would register a steady CAGR over 8.90% throughout the forecast period (2019–2025). Large-scale advancements in healthcare equipment manufacturing technologies and increasing spending on healthcare are the key driving forces of the market.

Additional factors that are further boosting the market growth, include the development of new and specialized surgical procedures to treat various neurological and head/neck trauma cases. Simultaneously, increasing numbers of geriatric populaces and the growing preference of minimally invasive surgeries push the market growth. Standardization of healthcare practices and procedures globally alongside, the critical need for head/neck stabilization during surgery fosters the growth of the market.

On the other hand, stringent regulations regarding the classification of cranial fixation & stabilization equipment as class II and class III medical devices is a key factor impeding the growth of the market. Also, different regulatory standards across the globe are expected to obstruct market growth, affecting imports and exports severely. Nevertheless, symbiotic growth of the healthcare & technology industries and emphasis on reducing patient mortality are two of the major factors that would support the growth of the market.

Global Cranial Fixation and Stabilization Market – Segments 

The report is segmented into five market dynamics to widen the scope of understanding

By Category : Cranial Fixation Systems and Cranial Stabilization Systems.

By Product : Meshes, Skull Clamps, Flap Tube Clamps, Horseshoe Headrests, Screws, and Accessories, among others.

By Type : Resorbable and Non- Resorbable. 

By End-user : Hospitals and Ambulatory Surgical Centers, among others. 

By Regions : Asia Pacific, North America, Europe, and the Rest-of-the-World.

Global Cranial Fixation and Stabilization Market - Regional Analysis

North America leads the global cranial fixation and stabilization market with a massive 55% of the market share. The region is heading with the increasing patient population suffering from neurological conditions such as epilepsy, stroke, neuroinfectious, and traumatic injuries which creates enormous market demand. Countries like the US and Canada, backed by substantial technological innovation and advancement in manufacturing processes of healthcare equipment, play a vital role in the growth of the regional market. 

Moreover, factors such as the increasing geriatric population alongside, the high healthcare expenditures and the increase in FDA approvals, substantiate the growth of cranial fixation and stabilization market in the region. Also, rising R&D funding to develop new technologies and specialized surgical procedures to treat various neurological and head/neck trauma cases are supporting the regional market growth.

The cranial fixation and stabilization market in the European region accounts for the second-largest market, globally. Factors such as the financial support from the government for research and development activities, increasing geriatric population, and the demand for cranial fixation and stabilization in the treatment procedures drive the market growth. However, the manufacture of medical equipment is subjected to stringent regulations. To fast track the regulatory process, the European Union (EU) has created a single body for all member countries, which befit medium- and small-scale manufacturers, directly. 

The Asia Pacific cranial fixation and stabilization market is emerging as a profitable market, globally. Rising cases of neurological disorders & head traumas requiring surgery along with the growing awareness in the region about this novel equipment drive the regional market growth. Moreover, increasing healthcare expenditure, government funding, and the rising investments in healthcare and expansions by market players are some of the key driving forces behind the growth of the regional market.

Global Cranial Fixation and Stabilization Market   - Competitive Analysis 

Highly competitive, the cranial fixation and stabilization market appears to be widely expanded and fragmented characterized by several small and large-scale players. To gain a competitive edge in the market, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, product launch, and expansion. These strategies, in turn, increases the profit of the company while reducing the competition, significantly. The acquisition of local manufactures by multinational companies changes the structure of the market. 

Major Players:

Players leading the global cranial fixation and stabilization market include Johnson & Johnson (US), Stryker (US), Ostomed (UK), KLS Martin Group (Germany), Medtronic (US), Integra LifeSciences Corporation (US), Braun Melsungen AG (Germany), Changzhou Huida (China), DePuy Synthes (US), Evonos (Germany), Jeil Medical (South Korea), Medicon (Germany), Micromar (Brazil), NEOS Surgery (Spain), Pro Med Instruments (Germany), and Zimmer Biomet (US), among others.

Industry/ Innovation/ Related News: 

August 15, 2019 ----- Medicrea Group (France), a leading global conglomerate dealing in development, manufacture, and distribution of surgical and other medical instruments, apparatus, and equipment, announced the receiving of FDA 510(k) clearance for its Tulip Genesis, a top-loading screw system. The clearance of Medicrea’s AI spine platform completes the ’company’s UNid ASI (Adaptive Spine Intelligence) proprietary platform technology. The Artificial Intelligence (AI) embedded within the platform allows a surgeon to visualize the compensatory mechanisms above and below the instrumented spine. 

Read Complete Report @ https://www.marketresearchfuture.com/reports/cranial-fixation-stabilization-market-8163 

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by Components, Application, Logistics and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact:
Market Research Future
Office No. 528, Amanora Chambers
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: sales@marketresearchfuture.com
Blog: https://healthcarenews12.blogspot.com/